On one hand, IBD can lead to dysregulation of adipokines, shifting the balance towards a pro-inflammatory state, on the other hand obesity and higher BMI are associated with higher risk of developing IBD and worse clinical outcomes, particularly for UC
Conclusion: The GLP-1 Race Is Becoming the Metabolic Health Race The GLP-1 revolution is no longer a narrow diabetes or obesity story
Chit xut ht hng dng v hoa hng trong thnh phn kem dng Glutathione 700 s gip duy tr m v lm trng da
Summary Naltrexone has long been a wonder drug in search of physicians willing to prescribe it and patients willing to take it
The potential for gastrointestinal adverse effects, particularly nausea and vomiting, may lead to dehydration and worsening of renal function in vulnerable patients
After 5 years, GLP-1 users had an 84 percent lower risk of developing dry AMD than the group taking other types of weight loss drugs